Hi Veeva Product Team,
Our end users have a need for the ability to control access to confidential, proprietary information during the submission review and approval of sensitive content at the document level, like they use to be able to do in Zinc MAPS. This need is particularly critical while awaiting product approval from the FDA, etc. The method we are currently using (suggested and implemented with the assistance of our Veeva Managed Services partner) to get as close as possible to mimicking that capability (via User Role Setup records, etc.) is not granular enough to meet the ultimate needs of our end users.
Is this capability of access control at the document level currently on Veeva's enhancement roadmap? Or would you please consider adding it?